tiprankstipranks
Trending News
More News >
Aoyuan Healthy Life Group Co. Ltd. (HK:3662)
:3662
Hong Kong Market
Advertisement

Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

Compare
1 Followers

Top Page

HK:3662

Aoyuan Healthy Life Group Co. Ltd.

(3662)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
HK$0.50
▲(4.17% Upside)
The overall stock score of 61 reflects a mixed outlook. The company's strong balance sheet and attractive valuation are offset by declining financial performance and bearish technical indicators. The lack of earnings call data and corporate events limits further insights. Investors should be cautious of the negative cash flow trends and bearish market momentum.

Aoyuan Healthy Life Group Co. Ltd. (3662) vs. iShares MSCI Hong Kong ETF (EWH)

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company DescriptionAoyuan Healthy Life Group Co. Ltd. (3662) is a diversified service provider headquartered in China, primarily engaged in property management and commercial operational services. The company caters to residential and non-residential properties, offering services such as property management, value-added services for residents, and commercial operational management. Aoyuan Healthy Life focuses on enhancing community living standards and optimizing commercial property operations through its comprehensive service offerings.
How the Company Makes MoneyAoyuan Healthy Life Group Co. Ltd. generates revenue primarily through its property management and commercial operational services. The property management segment includes fees for managing residential and non-residential properties, providing security, cleaning, landscaping, and maintenance services. The company also earns income from value-added services, which include consultancy for property developers, community living services for residents, and other ancillary services. The commercial operational services segment involves managing and leasing commercial properties, from which the company derives rental income and management fees. Strategic partnerships with property developers and local governments also play a crucial role in expanding its service portfolio and client base, contributing to its revenue growth.

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary
Aoyuan Healthy Life Group Co. Ltd. shows a mixed financial performance. The income statement reveals declining revenue and profitability margins, indicating challenges in maintaining growth and operational efficiency. The balance sheet is robust with low leverage and strong equity, suggesting resilience. However, cash flow analysis reveals potential concerns with negative operating cash flow, which may hinder future growth and investment capabilities.
Income Statement
65
Positive
The company has experienced declining revenue over the past few years, with a significant drop from 2020 to 2021, and a continued decline through 2024. Gross Profit Margin (28.41% in 2024) has been relatively stable, but Net Profit Margin has deteriorated, dropping from 17.83% in 2020 to 7.10% in 2024. The EBIT and EBITDA margins have also shown a downward trend, reflecting decreasing operational efficiency.
Balance Sheet
75
Positive
The company maintains a strong equity position with an Equity Ratio of 51.00% in 2024, indicating a solid foundation and reduced financial risk. The Debt-to-Equity Ratio is low at 0.07, showing conservative leverage management. Additionally, Return on Equity has decreased slightly over the years, reflecting reduced profitability. However, the company’s high cash reserves relative to its debt provide a buffer against financial instability.
Cash Flow
55
Neutral
The cash flow situation is mixed. Operating Cash Flow has turned negative in 2024, indicating potential challenges in generating cash from core operations. The Free Cash Flow has also declined, with significant negative trends in prior years. The ratio of Operating Cash Flow to Net Income has been inconsistent, showing volatility in cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.27B1.36B1.56B1.63B1.94B1.41B
Gross Profit334.58M385.04M399.62M397.21M469.57M488.68M
EBITDA115.61M160.95M198.54M245.27M-108.96M368.71M
Net Income39.56M96.22M157.14M160.41M-190.94M251.11M
Balance Sheet
Total Assets2.29B2.36B2.28B2.22B2.29B2.55B
Cash, Cash Equivalents and Short-Term Investments958.01M1.05B984.50M857.81M1.21B1.51B
Total Debt103.59M81.69M114.94M158.29M412.59M518.52M
Total Liabilities1.04B1.11B1.13B1.23B1.50B1.49B
Stockholders Equity1.21B1.20B1.10B931.48M747.32M1.04B
Cash Flow
Free Cash Flow75.76M107.61M93.52M-108.95M-98.54M505.54M
Operating Cash Flow107.38M140.33M106.01M-105.68M-86.34M531.10M
Investing Cash Flow-21.25M-30.53M67.93M-50.65M31.09M-225.22M
Financing Cash Flow-16.30M-51.28M-48.34M-272.10M-245.32M376.79M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.48
Price Trends
50DMA
0.53
Negative
100DMA
0.53
Negative
200DMA
0.52
Negative
Market Momentum
MACD
-0.01
Negative
RSI
37.39
Neutral
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Negative. The current price of 0.48 is above the 20-day moving average (MA) of 0.47, below the 50-day MA of 0.53, and below the 200-day MA of 0.52, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 37.39 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
HK$594.22M7.595.01%-31.83%
72
Outperform
HK$420.02M9.853.76%-3.62%26.66%
61
Neutral
HK$344.97M8.093.28%6.04%-14.43%-77.55%
57
Neutral
HK$318.21M-14.9413.08%6.30%-128.34%
49
Neutral
HK$353.28M40.000.88%-25.81%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3662
Aoyuan Healthy Life Group Co. Ltd.
0.48
-0.08
-14.29%
HK:9608
Sundy Service Group Co. Ltd
0.09
-0.01
-10.00%
HK:1922
Yincheng Life Service Co., Ltd.
1.36
0.00
0.00%
HK:2107
First Service Holding Limited
0.26
-0.08
-23.53%
HK:2165
Ling Yue Services Group Limited
2.08
0.50
31.65%
HK:2376
Lushang Life Services Co., Ltd. Class H
3.15
1.70
117.24%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Starjoy Wellness and Travel Announces Board Composition
May 29, 2025

Starjoy Wellness and Travel Company Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board is chaired by Mr. Wang Jiren, who also serves as the president, with Ms. Liang Jinrong as the chief financial officer and vice president. The announcement provides details on the roles and functions of each board member, as well as their membership in various board committees, which include audit, remuneration, and nomination committees.

Starjoy Wellness Updates Nomination Committee Terms
May 29, 2025

Starjoy Wellness and Travel Company Limited has amended and restated the terms of reference for its Nomination Committee. The committee, consisting of at least three members with a majority being independent non-executive directors, is responsible for overseeing nominations to the board. This move aims to ensure diverse and independent oversight in board appointments, potentially enhancing governance and strategic decision-making within the company.

Starjoy Wellness and Travel Updates Nomination Committee for Enhanced Governance
May 29, 2025

Starjoy Wellness and Travel Company Limited has announced a change in the composition of its Nomination Committee. Ms. Liang Jinrong, an executive director, has been appointed as a member of the Nomination Committee, effective from May 29, 2025. This change aligns with the amended Corporate Governance Code, which will be effective from July 1, 2025, and aims to enhance the company’s corporate governance by increasing diversity and effectiveness within the board.

Starjoy Wellness and Travel Company Limited Secures Shareholder Approval for Key Resolutions at AGM
May 27, 2025

Starjoy Wellness and Travel Company Limited, along with its subsidiaries, held its Annual General Meeting on May 27, 2025, where all proposed resolutions were approved by shareholders. The resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share repurchase and issuance. The unanimous approval of these resolutions reflects strong shareholder support and positions the company for continued operational and strategic initiatives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 30, 2025